News

Recognizing Innovation: The Inaugural Ramin Tadayoni Award Ceremony

Recognizing Innovation: The Inaugural Ramin Tadayoni Award Ceremony

Celebrating Innovation in Eye Care

Oculis Holding AG (Nasdaq: OCS) has teamed up with EURETINA to mark a significant achievement in ophthalmology—the creation of the Ramin Tadayoni Award. This esteemed award, revealed in Zug, Switzerland, honors the impactful work of Professor Ramin Tadayoni, a highly esteemed retina expert and Chief Scientific Officer at Oculis, who tragically passed away earlier this year.

About the Ramin Tadayoni Award

The Ramin Tadayoni Award is designed to recognize and inspire the next generation of researchers committed to making strides in retinal studies. It pays homage to Professor Tadayoni’s incredible legacy, highlighting the importance of innovation in eye care research. The first recipient of the award is Andrea Govetto, M.D., Ph.D., whose pioneering research focuses on developing a computational model to analyze fluid flow and tissue deformation in macular edema, an essential area in ophthalmology.

Recognizing Exceptional Talent

Anat Loewenstein, M.D., President of EURETINA, expressed her appreciation to the applicants who submitted more than 50 competitive proposals for this award. Dr. Loewenstein congratulated Dr. Govetto, noting that his research aligns seamlessly with the contributions made by Professor Tadayoni to the field.

Insights from the CEO

Riad Sherif, M.D., Chief Executive Officer of Oculis, shared his perspective on the collaboration for this award, stating, “We are proud to be part of this initiative alongside EURETINA and extend our sincere congratulations to Dr. Govetto. His commitment to enhancing research on retinal diseases and improving patient care truly embodies the spirit of this award.”

A Promising Future for Retina Research

Dr. Andrea Govetto is a skilled vitreoretinal surgeon at the Oftalmico-Fatebenefratelli Hospital in Milan, Italy. He has dedicated his work to understanding the complexities of retinal pathology, especially concerning retinal detachment and the intricate issues surrounding lamellar macular holes and epiretinal membranes. His extensive training encompasses a specialization in ophthalmology in Spain and clinical fellowships at the prestigious Stein Eye Institute at UCLA and the Bristol Eye Hospital in the U.K.

The Award Ceremony

This annual award not only offers significant financial support, providing €30,000 for ongoing research efforts and an extra €5,000 for the awardee, but it also nurtures the next generation of outstanding ophthalmologists focused on retina innovation. The award was presented at the opening ceremony of the EURETINA congress, an important event for ophthalmology professionals taking place over several days in Barcelona.

About Oculis

Oculis is a forward-thinking biopharmaceutical company dedicated to improving eye health through innovative research. With a diverse pipeline that includes promising candidates like OCS-01 for diabetic macular edema and OCS-02 for dry eye disease, Oculis aims to enhance the quality of life for patients around the globe. Headquartered in Switzerland, the company operates in both the U.S. and Iceland, supported by a strong management team and distinguished healthcare investors who share its vision for advancing ophthalmic care.

Reaching Out to Oculis

For further information about Oculis and its research projects, interested parties can connect with the company through various channels. Ms. Sylvia Cheung, the CFO, is available for inquiries, and additional media relations contact details can be found through their dedicated channels.

Frequently Asked Questions

What is the Ramin Tadayoni Award?

The Ramin Tadayoni Award honors innovative research in retinal health, recognizing outstanding young ophthalmologists.

Who was the first recipient of the Ramin Tadayoni Award?

Andrea Govetto, M.D., Ph.D., was awarded for his work on fluid flow and retinal tissue deformation in macular edema.

What did Dr. Govetto's research focus on?

His research centers on understanding fluid dynamics and tissue changes associated with retinal diseases, notably macular edema.

What financial support does the award offer?

The annual award provides €30,000 for research support and an additional €5,000 for the awardee.

How does Oculis contribute to eye care?

Oculis develops innovative biopharmaceutical solutions aimed at improving sight and treating various ocular conditions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 445

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
AutoShop Answers Extends 2027 Training Into Fridays

Updated Category News Views 60

A repair bay can hum all day while the back office quietly bleeds profit. That unglamorous reality is why AutoShop Answers adding nine Friday specialty classes to its 2027 Key2Key Weekend calendar deserves a closer look. This is not a new tool chest or some vague motivational roadshow; it is an attempt to give independent shop owners an extra day to work on the pieces...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 385

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
EyePoint Lawsuit Puts DURAVYU Claims Under a Microscope

Updated Category News Views 50

Nothing makes biotech investors reach for the aspirin faster than a lawsuit centered on whether a drug worked as advertised. EyePoint, Inc. is facing a proposed federal securities class action alleging that the company overstated the effectiveness of DURAVYU and, by extension, its clinical, regulatory, and commercial prospects. That is a serious allegation, but it remains...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading

Top 5 Most Recently Viewed Articles

Northern Trust Adjusts Prime Rate to Enhance Financial Services

Updated Category News Views 90

Northern Trust Lowers Its Prime Rate Northern Trust has made an important change by reducing its prime rate from 8.50% to 8.00%. This adjustment takes effect immediately and demonstrates the company's commitment to offering competitive financial solutions. The Impact of Changes in the Prime Rate The prime rate serves as the benchmark interest rate that banks provide to...

Continue Reading
Experiencing Luxury with CÎROC at TGL's Prime Events

Updated Category News Views 225

Exciting Partnership Announced for TGL Events TGL, a premier team golf league, has named CÎROC Ultra-Premium Vodka as its Official Vodka Partner. This collaboration marks a new era of luxury, promising a unique experience for fans and attendees at TGL events. The partnership aims to elevate the leisure experience that TGL provides, integrating elegance and sophistication...

Continue Reading
Global Wellness Institute Introduces Groundbreaking Podcast

Updated Category News Views 413

Global Wellness Institute Unveils Innovative Podcast The Global Wellness Institute (GWI) has launched an exciting new podcast titled The Wellness Roundtable: Longevity. This podcast aims to delve into the intricate science and strategies behind improving longevity and healthspan. Bringing forth expert insights, this series shifts the narrative from abstract theories to...

Continue Reading
Kennedy-Wilson Welcomes New Leaders to Its Board for Growth

Updated Category News Views 106

Kennedy-Wilson Welcomes New Leaders to Its Board Kennedy-Wilson Holdings, Inc. (NYSE: KW), a global real estate investment company, has made noteworthy strides by appointing two new independent directors to its Board. This strategic decision is indicative of the company’s aim to reinforce its governance during a pivotal time in the real estate market. Introducing the...

Continue Reading
MoxiWorks Transforms Strategy with MoxiBalance's Sale to Upfront

Updated Category News Views 285

MoxiWorks Sells MoxiBalance to Upfront for Strategic Growth The recent sale of MoxiBalance by MoxiWorks represents a significant strategic shift, allowing the company to prioritize its core mission of empowering real estate agents. The transition will enable MoxiWorks to concentrate on enhancing sales and marketing solutions while providing Upfront, known for its...

Continue Reading